JAGUAR HEALTH, INC. (JAGX) Current Ratio
- Current ratio · latest quarter: Value 0.69×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.69× | Current assets / current liabilities. $17.53M ÷ $25.38M ≈ 0.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 17.53M USD | Assets, Current |
| Current obligations | 25.38M USD | Liabilities, Current |
| Cash and equivalents | 3.79M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 8.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 7.32M USD | Inventory, Net |
| Payables | 4.79M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.53M | $25.38M | $3.79M | (m) | $8.00K | $7.32M | $4.79M | (m) | 0.69× |
| 2026-03-31 | $20.21M | $40.69M | $7.28M | (m) | $68.00K | $7.82M | $4.96M | (m) | 0.50× |
| 2025-12-31 | $20.34M | $40.65M | $968.00K | (m) | $1.52M | $8.60M | $8.69M | (m) | 0.50× |
| 2025-09-30 | $29.40M | $36.12M | $3.53M | (m) | $1.44M | $10.63M | $8.44M | (m) | 0.81× |
| 2025-06-30 | $27.90M | $29.22M | $2.21M | (m) | $1.17M | $10.72M | $6.62M | (m) | 0.95× |
| 2025-03-31 | $30.44M | $28.21M | $5.69M | (m) | $1.22M | $10.55M | $7.03M | (m) | 1.08× |
| 2024-12-31 | $32.20M | $19.70M | $8.00M | (m) | $1.53M | $10.35M | $5.29M | (m) | 1.63× |
| 2024-09-30 | $36.64M | $19.87M | $13.27M | (m) | $1.25M | $9.67M | $4.55M | (m) | 1.84× |
| 2024-06-30 | $40.11M | $19.13M | $16.05M | (m) | $1.30M | $9.56M | $4.09M | (m) | 2.10× |
| 2024-03-31 | $33.71M | $17.81M | $11.67M | (m) | $1.51M | $9.02M | $3.32M | (m) | 1.89× |
| 2023-12-31 | $27.96M | $13.99M | $6.47M | (m) | $1.97M | $9.19M | $4.97M | (m) | 2.00× |
| 2023-09-30 | $22.06M | $12.46M | $3.23M | (m) | $1.67M | $8.38M | $5.13M | (m) | 1.77× |
| 2023-06-30 | $28.23M | $29.00M | $8.63M | (m) | $1.40M | $8.26M | $4.66M | (m) | 0.97× |
| 2023-03-31 | $32.36M | $31.10M | $14.37M | (m) | $987.00K | $8.68M | $5.69M | (m) | 1.04× |
| 2022-12-31 | $22.32M | $30.34M | $5.47M | (m) | $1.88M | $7.02M | $5.81M | (m) | 0.74× |
| 2022-09-30 | $25.21M | $26.94M | $10.56M | (m) | $1.82M | $6.60M | $6.29M | (m) | 0.94× |
| 2022-06-30 | $23.36M | $22.90M | $9.01M | (m) | $1.55M | $6.75M | $5.64M | (m) | 1.02× |
| 2022-03-31 | $28.47M | $19.09M | $17.46M | (m) | $1.79M | $4.88M | $3.71M | (m) | 1.49× |
| 2021-12-31 | $28.43M | $15.47M | $17.05M | (m) | $1.71M | $4.90M | $4.93M | (m) | 1.84× |
| 2021-09-30 | $24.00M | $11.95M | $12.38M | (m) | $2.11M | $4.51M | $3.79M | (m) | 2.01× |
| 2021-06-30 | $44.29M | $12.65M | $21.99M | (m) | $4.13M | $3.40M | $4.92M | (m) | 3.50× |
| 2021-03-31 | $44.10M | $12.59M | $32.25M | (m) | $5.90M | $2.82M | $4.74M | (m) | 3.50× |
| 2020-12-31 | $17.79M | $13.22M | (m) | (m) | $2.10M | $2.78M | $4.76M | (m) | 1.35× |
| 2020-09-30 | $10.72M | $25.77M | $1.35M | (m) | $1.50M | $2.22M | $5.46M | (m) | 0.42× |
| 2020-06-30 | $11.61M | $24.76M | $3.02M | (m) | $2.21M | $2.35M | $5.24M | (m) | 0.47× |
| 2020-03-31 | $6.84M | $16.27M | $1.22M | (m) | $1.08M | $2.70M | $5.60M | (m) | 0.42× |
| 2019-12-31 | $9.52M | $15.39M | $3.50M | (m) | $1.69M | $2.13M | $5.35M | (m) | 0.62× |
| 2019-09-30 | $7.55M | $8.57M | $2.07M | (m) | $1.59M | $2.32M | $4.75M | (m) | 0.88× |
| 2019-06-30 | $7.35M | $20.84M | $1.61M | (m) | $2.10M | $2.39M | $6.39M | (m) | 0.35× |
| 2019-03-31 | $7.32M | $24.75M | $2.57M | (m) | $914.76K | $2.96M | $6.56M | (m) | 0.30× |
| 2018-12-31 | $8.15M | $26.66M | $2.57M | (m) | $995.68K | $3.34M | $5.41M | (m) | 0.31× |
| 2018-09-30 | $7.50M | $16.14M | $726.13K | (m) | $1.03M | $2.55M | $6.45M | $0.00 | 0.46× |
| 2018-06-30 | $6.88M | $12.37M | $2.41M | (m) | $583.61K | $2.84M | $5.00M | $0.00 | 0.56× |
| 2018-03-31 | $10.87M | $9.38M | $7.81M | (m) | $362.81K | $2.33M | $3.16M | $0.00 | 1.16× |
| 2017-12-31 | $3.80M | $15.39M | $520.70K | (m) | $467.66K | $2.07M | $7.35M | $1.61M | 0.25× |
| 2017-09-30 | $4.24M | $16.03M | $220.59K | (m) | $759.18K | $1.83M | $7.86M | $1.80M | 0.26× |
| 2017-06-30 | $3.96M | $10.36M | $2.76M | (m) | $12.19K | $396.18K | $3.44M | $2.07M | 0.38× |
| 2017-03-31 | $2.58M | $8.43M | $1.21M | (m) | (m) | $392.64K | $1.47M | $1.99M | 0.31× |
| 2016-12-31 | $2.56M | $4.19M | $950.98K | (m) | $4.96K | $412.75K | $517.00K | $1.92M | 0.61× |
| 2016-09-30 | $4.08M | $3.10M | $1.81M | (m) | $4.96K | $276.23K | $443.73K | $1.85M | 1.32× |
| 2016-06-30 | $5.02M | $2.95M | $3.88M | (m) | $19.11K | $276.62K | $413.82K | $1.47M | 1.70× |
| 2016-03-31 | $8.12M | $3.69M | $7.21M | (m) | $12.80K | $269.63K | $559.86K | $2.12M | 2.20× |
| 2015-12-31 | $8.45M | $3.91M | $7.70M | (m) | $55.87K | $229.87K | $574.46K | $1.71M | 2.16× |
| 2015-09-30 | $11.10M | $3.82M | $10.38M | (m) | $8.70K | $256.13K | $276.77K | $1.45M | 2.91× |
| 2015-06-30 | $12.87M | $2.74M | $12.38M | (m) | $29.39K | $306.72K | $349.10K | (m) | 4.69× |
| 2015-03-31 | $3.98M | $9.21M | $746.34K | (m) | $8.14K | $314.21K | $1.76M | (m) | 0.43× |
| 2014-12-31 | $3.55M | $3.48M | $845.19K | (m) | (m) | $198.03K | $698.32K | (m) | 1.02× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |